These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22994211)

  • 1. The objectivity of reporters: interference between physically unlinked promoters affects reporter gene expression in transient transfection experiments.
    Huliák I; Sike A; Zencir S; Boros IM
    DNA Cell Biol; 2012 Nov; 31(11):1580-4. PubMed ID: 22994211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In trans promoter activation by enhancers in transient transfection.
    Smirnov NA; Akopov SB; Didych DA; Nikolaev LG
    Gene; 2017 Mar; 603():15-20. PubMed ID: 27956170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity.
    Gribaudo G; Ravaglia S; Gaboli M; Gariglio M; Cavallo R; Landolfo S
    Virology; 1995 Aug; 211(1):251-60. PubMed ID: 7645218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
    Al-Dosari M; Zhang G; Knapp JE; Liu D
    Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
    Yan Y; Dalmasso G; Sitaraman S; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
    Konopka K; Lee NS; Rossi J; Düzgüneş N
    Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a reporter vector for analysis of bidirectional transcriptional activity of retrovirus LTR.
    Arpin-André C; Laverdure S; Barbeau B; Gross A; Mesnard JM
    Plasmid; 2014 Jul; 74():45-51. PubMed ID: 24971710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent enhancement of transcriptional activity and specificity of a retinal pigment epithelial cell-preferential promoter.
    Zhang D; Sutanto EN; Rakoczy PE
    Mol Vis; 2004 Mar; 10():208-14. PubMed ID: 15064682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of promoter regions in the human genome by using a retroviral plasmid library-based functional reporter gene assay.
    Khambata-Ford S; Liu Y; Gleason C; Dickson M; Altman RB; Batzoglou S; Myers RM
    Genome Res; 2003 Jul; 13(7):1765-74. PubMed ID: 12805274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain.
    Liu BH; Yang Y; Paton JF; Li F; Boulaire J; Kasparov S; Wang S
    Mol Ther; 2006 Dec; 14(6):872-82. PubMed ID: 16904943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M; Hill SA; Derse D
    Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
    Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
    Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient expression of luciferase reporter gene after lipofection in oyster (Crassostrea gigas) primary cell cultures.
    Boulo V; Cadoret JP; Le Marrec F; Dorange G; Miahle E
    Mol Mar Biol Biotechnol; 1996 Sep; 5(3):167-74. PubMed ID: 8817924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 long terminal repeat promoter regulated dual reporter: potential use in screening of transcription modulators.
    Ravi DS; Mitra D
    Anal Biochem; 2007 Jan; 360(2):315-7. PubMed ID: 17141170
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
    Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
    Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving transcriptional activity of human cytomegalovirus major immediate-early promoter by mutating NF-κB binding sites.
    Wang D; Dai W; Wu J; Wang J
    Protein Expr Purif; 2018 Feb; 142():16-24. PubMed ID: 28941824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of NF-κB transcriptional activity and identification of NF-κB cis-regulatory elements using luciferase assays.
    Collins PE; O'Carroll C; Carmody RJ
    Methods Mol Biol; 2015; 1280():25-43. PubMed ID: 25736742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.